Cargando…
Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial
BACKGROUND: Apples are rich in bioactive polyphenols and fiber. Evidence suggests that consumption of apples or their bioactive components is associated with beneficial effects on lipid metabolism and other markers of cardiovascular disease (CVD). However, adequately powered randomized controlled tr...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997084/ https://www.ncbi.nlm.nih.gov/pubmed/31840162 http://dx.doi.org/10.1093/ajcn/nqz282 |
_version_ | 1783493619497304064 |
---|---|
author | Koutsos, Athanasios Riccadonna, Samantha Ulaszewska, Maria M Franceschi, Pietro Trošt, Kajetan Galvin, Amanda Braune, Tanya Fava, Francesca Perenzoni, Daniele Mattivi, Fulvio Tuohy, Kieran M Lovegrove, Julie A |
author_facet | Koutsos, Athanasios Riccadonna, Samantha Ulaszewska, Maria M Franceschi, Pietro Trošt, Kajetan Galvin, Amanda Braune, Tanya Fava, Francesca Perenzoni, Daniele Mattivi, Fulvio Tuohy, Kieran M Lovegrove, Julie A |
author_sort | Koutsos, Athanasios |
collection | PubMed |
description | BACKGROUND: Apples are rich in bioactive polyphenols and fiber. Evidence suggests that consumption of apples or their bioactive components is associated with beneficial effects on lipid metabolism and other markers of cardiovascular disease (CVD). However, adequately powered randomized controlled trials are necessary to confirm these data and explore the mechanisms. OBJECTIVE: We aimed to determine the effects of apple consumption on circulating lipids, vascular function, and other CVD risk markers. METHODS: The trial was a randomized, controlled, crossover, intervention study. Healthy mildly hypercholesterolemic volunteers (23 women, 17 men), with a mean ± SD BMI 25.3 ± 3.7 kg/m(2) and age 51 ± 11 y, consumed 2 apples/d [Renetta Canada, rich in proanthocyanidins (PAs)] or a sugar- and energy-matched apple control beverage (CB) for 8 wk each, separated by a 4-wk washout period. Fasted blood was collected before and after each treatment. Serum lipids, glucose, insulin, bile acids, and endothelial and inflammation biomarkers were measured, in addition to microvascular reactivity, using laser Doppler imaging with iontophoresis, and arterial stiffness, using pulse wave analysis. RESULTS: Whole apple (WA) consumption decreased serum total (WA: 5.89 mmol/L; CB: 6.11 mmol/L; P = 0.006) and LDL cholesterol (WA: 3.72 mmol/L; CB: 3.86 mmol/L; P = 0.031), triacylglycerol (WA: 1.17 mmol/L; CB: 1.30 mmol/L; P = 0.021), and intercellular cell adhesion molecule-1 (WA: 153.9 ng/mL; CB: 159.4 ng/mL; P = 0.028), and increased serum uric acid (WA: 341.4 μmol/L; CB: 330 μmol/L; P = 0.020) compared with the CB. The response to endothelium-dependent microvascular vasodilation was greater after the apples [WA: 853 perfusion units (PU), CB: 760 PU; P = 0.037] than after the CB. Apples had no effect on blood pressure or other CVD markers. CONCLUSIONS: These data support beneficial hypocholesterolemic and vascular effects of the daily consumption of PA-rich apples by mildly hypercholesterolemic individuals. This trial was registered at clinicaltrials.gov as NCT01988389. |
format | Online Article Text |
id | pubmed-6997084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-69970842020-02-10 Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial Koutsos, Athanasios Riccadonna, Samantha Ulaszewska, Maria M Franceschi, Pietro Trošt, Kajetan Galvin, Amanda Braune, Tanya Fava, Francesca Perenzoni, Daniele Mattivi, Fulvio Tuohy, Kieran M Lovegrove, Julie A Am J Clin Nutr Original Research Communications BACKGROUND: Apples are rich in bioactive polyphenols and fiber. Evidence suggests that consumption of apples or their bioactive components is associated with beneficial effects on lipid metabolism and other markers of cardiovascular disease (CVD). However, adequately powered randomized controlled trials are necessary to confirm these data and explore the mechanisms. OBJECTIVE: We aimed to determine the effects of apple consumption on circulating lipids, vascular function, and other CVD risk markers. METHODS: The trial was a randomized, controlled, crossover, intervention study. Healthy mildly hypercholesterolemic volunteers (23 women, 17 men), with a mean ± SD BMI 25.3 ± 3.7 kg/m(2) and age 51 ± 11 y, consumed 2 apples/d [Renetta Canada, rich in proanthocyanidins (PAs)] or a sugar- and energy-matched apple control beverage (CB) for 8 wk each, separated by a 4-wk washout period. Fasted blood was collected before and after each treatment. Serum lipids, glucose, insulin, bile acids, and endothelial and inflammation biomarkers were measured, in addition to microvascular reactivity, using laser Doppler imaging with iontophoresis, and arterial stiffness, using pulse wave analysis. RESULTS: Whole apple (WA) consumption decreased serum total (WA: 5.89 mmol/L; CB: 6.11 mmol/L; P = 0.006) and LDL cholesterol (WA: 3.72 mmol/L; CB: 3.86 mmol/L; P = 0.031), triacylglycerol (WA: 1.17 mmol/L; CB: 1.30 mmol/L; P = 0.021), and intercellular cell adhesion molecule-1 (WA: 153.9 ng/mL; CB: 159.4 ng/mL; P = 0.028), and increased serum uric acid (WA: 341.4 μmol/L; CB: 330 μmol/L; P = 0.020) compared with the CB. The response to endothelium-dependent microvascular vasodilation was greater after the apples [WA: 853 perfusion units (PU), CB: 760 PU; P = 0.037] than after the CB. Apples had no effect on blood pressure or other CVD markers. CONCLUSIONS: These data support beneficial hypocholesterolemic and vascular effects of the daily consumption of PA-rich apples by mildly hypercholesterolemic individuals. This trial was registered at clinicaltrials.gov as NCT01988389. Oxford University Press 2020-02 2019-12-16 /pmc/articles/PMC6997084/ /pubmed/31840162 http://dx.doi.org/10.1093/ajcn/nqz282 Text en Copyright © The Author(s) 2019. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Communications Koutsos, Athanasios Riccadonna, Samantha Ulaszewska, Maria M Franceschi, Pietro Trošt, Kajetan Galvin, Amanda Braune, Tanya Fava, Francesca Perenzoni, Daniele Mattivi, Fulvio Tuohy, Kieran M Lovegrove, Julie A Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial |
title | Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial |
title_full | Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial |
title_fullStr | Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial |
title_full_unstemmed | Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial |
title_short | Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial |
title_sort | two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial |
topic | Original Research Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997084/ https://www.ncbi.nlm.nih.gov/pubmed/31840162 http://dx.doi.org/10.1093/ajcn/nqz282 |
work_keys_str_mv | AT koutsosathanasios twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT riccadonnasamantha twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT ulaszewskamariam twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT franceschipietro twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT trostkajetan twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT galvinamanda twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT braunetanya twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT favafrancesca twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT perenzonidaniele twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT mattivifulvio twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT tuohykieranm twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial AT lovegrovejuliea twoapplesadaylowerserumcholesterolandimprovecardiometabolicbiomarkersinmildlyhypercholesterolemicadultsarandomizedcontrolledcrossovertrial |